Mechanisms of neurotransmitter release by amphetamines: a review

Prog Neurobiol. 2005 Apr;75(6):406-33. doi: 10.1016/j.pneurobio.2005.04.003.

Abstract

Amphetamine and substituted amphetamines, including methamphetamine, methylphenidate (Ritalin), methylenedioxymethamphetamine (ecstasy), and the herbs khat and ephedra, encompass the only widely administered class of drugs that predominantly release neurotransmitter, in this case principally catecholamines, by a non-exocytic mechanism. These drugs play important medicinal and social roles in many cultures, exert profound effects on mental function and behavior, and can produce neurodegeneration and addiction. Numerous questions remain regarding the unusual molecular mechanisms by which these compounds induce catecholamine release. We review current issues on the two apparent primary mechanisms--the redistribution of catecholamines from synaptic vesicles to the cytosol, and induction of reverse transport of transmitter through plasma membrane uptake carriers--and on additional drug effects that affect extracellular catecholamine levels, including uptake inhibition, effects on exocytosis, neurotransmitter synthesis, and metabolism.

Publication types

  • Review

MeSH terms

  • Amphetamines / pharmacology*
  • Animals
  • Carrier Proteins / drug effects
  • Carrier Proteins / metabolism
  • Catecholamines / metabolism*
  • Central Nervous System Stimulants / pharmacology
  • Exocytosis / drug effects
  • Exocytosis / physiology
  • Humans
  • Neurotransmitter Agents / metabolism*
  • Neurotransmitter Uptake Inhibitors / pharmacology
  • Presynaptic Terminals / drug effects*
  • Presynaptic Terminals / metabolism*
  • Synaptic Membranes / drug effects*
  • Synaptic Membranes / metabolism
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / metabolism

Substances

  • Amphetamines
  • Carrier Proteins
  • Catecholamines
  • Central Nervous System Stimulants
  • Neurotransmitter Agents
  • Neurotransmitter Uptake Inhibitors